Fab-based bispecific antibody formats with robust biophysical properties and biological activity |
| |
Authors: | Xiufeng Wu Arlene J Sereno Flora Huang Steven M Lewis Ricky L Lieu Caroline Weldon Carina Torres Cody Fine Micheal A Batt Jonathan R Fitchett Andrew L Glasebrook Brian Kuhlman Stephen J Demarest |
| |
Affiliation: | 1.Eli Lilly Biotechnology Center; San Diego, CA, USA;2.Department of Biochemistry and Biophysics; University of North Carolina at Chapel Hill; Chapel Hill, NC, USA;3.Lineberger Comprehensive Cancer Center; University of North Carolina at Chapel Hill; Chapel Hill, NC, USA |
| |
Abstract: | A myriad of innovative bispecific antibody (BsAb) platforms have been reported. Most require significant protein engineering to be viable from a development and manufacturing perspective. Single-chain variable fragments (scFvs) and diabodies that consist only of antibody variable domains have been used as building blocks for making BsAbs for decades. The drawback with Fv-only moieties is that they lack the native-like interactions with CH1/CL domains that make antibody Fab regions stable and soluble. Here, we utilize a redesigned Fab interface to explore 2 novel Fab-based BsAbs platforms. The redesigned Fab interface designs limit heavy and light chain mixing when 2 Fabs are co-expressed simultaneously, thus allowing the use of 2 different Fabs within a BsAb construct without the requirement of one or more scFvs. We describe the stability and activity of a HER2×HER2 IgG-Fab BsAb, and compare its biophysical and activity properties with those of an IgG-scFv that utilizes the variable domains of the same parental antibodies. We also generated an EGFR × CD3 tandem Fab protein with a similar format to a tandem scFv (otherwise known as a bispecific T cell engager or BiTE). We show that the Fab-based BsAbs have superior biophysical properties compared to the scFv-based BsAbs. Additionally, the Fab-based BsAbs do not simply recapitulate the activity of their scFv counterparts, but are shown to possess unique biological activity. |
| |
Keywords: | Fab interface design bispecific antibody tandem Fab IgG-Fab T cell |
|
|